Total revenue from operations increased to ₹8,646 crore during the quarter as compared with ₹7,979 crore in the year-ago period, the drug firm said in a statement
Total revenue from operations increased to ₹8,646 crore during the quarter as compared with ₹7,979 crore in the year-ago period, the drug firm said in a statement by Soban News (international And National News)